ADAM10 and breast carcinoma: Mechanistic investigation unraveled miR-891a-5p but not miR-383-5p impeded the expression of the downstream target ADAM10 by directly binding to its 3'UTR, leading to the inhibition of breast cancer cells proliferation and migration.